secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ernexa Therapeutics Inc. (ERNA)
CIK:        0000748592
Form:       8-K
Filed at:   2023-01-26T23:59:59+00:00
Accession:  0001140361-23-002909
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Eterna Therapeutics CMO Dr. Roger Sidhu resigns effective Jan 31, 2023
----------------------------------------------------------------------

- Dr. Roger Sidhu, Chief Medical Officer, resigned on Jan 20, 2023 with effective date Jan 31, 2023.
- No replacement or interim CMO has been announced in the filing.
- Departure is effective immediately at the end of January 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/748592/000114036123002909/0001140361-23-002909-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/748592/000114036123002909/brhc10046926_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-002909

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer